Johnson & Johnson Announces Commitment To Adopt Revised PhRMA Marketing Code for Responsible Interactions With Healthcare Professionals

NEW BRUNSWICK, N.J., July 10 Johnson & Johnsontoday announced the commitment by its pharmaceutical companies to adopt therevised Pharmaceutical Research and Manufacturers of America (PhRMA) Code onInteractions with Healthcare Professionals. PhRMA introduced its new Codeearlier today.

Maintaining ethical relationships with health care professionals is anessential aspect of providing physicians with the valuable informationregarding the appropriate use of medicines needed to help provide the bestpossible care for patients. Acceptance of the revised PhRMA Code is consistentwith Johnson & Johnson's ongoing commitment to ensure the integrity of ourrelationships between representatives and doctors, as well as to protectmedical judgment and treatment choices from inappropriate influence.

The revised Code will supplement and enhance measures adopted by Johnson &Johnson and its pharmaceutical operating companies in 2002 when the firstPhRMA Code was introduced. Operating companies within our PharmaceuticalsGroup will implement the new guidance by January 2009.

Johnson & Johnson and its involved operating companies base theirguidelines for responsible interactions with doctors on industry codes ofconduct as well as the legal, regulatory and professional requirements of thecountries where we conduct business.

SOURCE Johnson & Johnson

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...